GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 70 or 1.0 percent, to $67.94. Bristol-Myers Squibb Co. rose$. 14 or. 3 percent, to $50.56. Hospira fell$. 20 or. 4 percent, to $49.87.

  • Most active New York Stock Exchange-traded stocks Monday, 20 Oct 2014 | 1:23 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Advanced Micro Devices Inc. fell 1.8 percent to $2.67 with 28,481,300 shares traded. Bank of America Corp. rose. 3 percent to $16.26 with 75,104,500 shares traded.

  • Midday Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 1:23 PM ET

    Baxter International Inc. rose$. 18 or. 3 percent, to $67.42. Bristol-Myers Squibb Co. fell$. 17 or. 3 percent, to $50.25. Hospira fell$. 18 or. 4 percent, to $49.89.

  • Early Glance: Pharmaceuticals companies Monday, 20 Oct 2014 | 10:40 AM ET

    Baxter International Inc. rose$. 02 or percent, to $67.26. Bristol-Myers Squibb Co. rose$. 03 or. 1 percent, to $50.45. Hospira rose$. 25 or. 5 percent, to $50.32.

  • US STOCKS-S&P edges higher but IBM results drag Dow Monday, 20 Oct 2014 | 9:54 AM ET

    *IBM slumps after quarterly results. NEW YORK, Oct 20- U.S. stocks were mixed on Monday, with the S&P 500 and Nasdaq posting modest gains, but the Dow falling as quarterly results from IBM disappointed. IBM shares slumped 7.3 percent to $168.69 as the biggest drag on both the Dow and S&P 500 after the company's third-quarter earnings fell well short of Wall Street...

  • Anti-abuse label approved for painkiller Embeda Friday, 17 Oct 2014 | 7:35 PM ET

    The FDA said Friday that Pfizer Inc.' s Embeda can have labeling indicating that it has properties expected to reduce abuse of the drug when it is crushed and taken orally or snorted. The FDA has been under intense public pressure to combat the national epidemic of prescription opioid abuse. Embeda is the third extended-release opioid to be approved with...

  • Final Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 94 or 1.4 percent, to $67.24. Bristol-Myers Squibb Co. rose $1.20 or 2.4 percent, to $50.42. Hospira rose$. 40 or. 8 percent, to $50.07.

  • Midday Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 1:21 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $67.83. Bristol-Myers Squibb Co. rose $1.49 or 3.0 percent, to $50.71. Hospira rose$. 36 or. 7 percent, to $50.03.

  • Most active New York Stock Exchange-traded stocks Friday, 17 Oct 2014 | 1:21 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AK Steel Holding Corp. rose 9.4 percent to $6.30 with 25,224,900 shares traded. AbbVie rose. 9 percent to $53.37 with 31,805,800 shares traded.

  • Early Glance: Pharmaceuticals companies Friday, 17 Oct 2014 | 10:39 AM ET

    Baxter International Inc. fell$. 47 or. 7 percent, to $67.71. Bristol-Myers Squibb Co. rose$. 49 or 1.0 percent, to $49.71. Hospira fell$. 19 or. 4 percent, to $49.48.

  • NEW YORK, Oct 17- U.S. stocks were higher at the open on Friday, following a batch of solid earnings reports that eased concerns about the impact of weak global demand on U.S. growth and businesses. General Electric shares rose 2.8 percent to $24.94 after the company reported third-quarter earnings that topped analyst expectations, pushing the S&P industrial...

  • Final Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $68.18. Bristol-Myers Squibb Co. rose$. 26 or. 5 percent, to $49.22. Hospira rose $1.55 or 3.2 percent, to $49.67.

  • Oct 16- Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday. The panel agreed to revisit its stance on the warning label once data from Pfizer's post-marketing study of Chantix is available.

  • FDA panel votes to keep boxed warning on Chantix Thursday, 16 Oct 2014 | 4:10 PM ET

    WASHINGTON— Federal health advisers say a bold-letter warning about suicide risks with Pfizer's Chantix should remain on the anti-smoking drug until it can reevaluated based on new, rigorous study information. Eleven advisers to the Food and Drug Administration voted to retain the so-called black box warning about reports of suicide, hostility and...

  • Can health-care stock funds stay on top? Thursday, 16 Oct 2014 | 2:53 PM ET

    NEW YORK— When swings in the stock market cause anxiety to spike, like it is now, many investors aim to get healthy. Stocks don't come with guarantees, but health care stocks have held up better than others during past downturns. People get sick regardless of the economy's strength, after all, and an aging population around the world means more demand for...

  • Most active New York Stock Exchange-traded stocks Thursday, 16 Oct 2014 | 1:21 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AbbVie fell 3.2 percent to $52.90 with 57,113,900 shares traded. Advanced Micro Devices Inc. rose 1.1 percent to $2.64 with 36,641,000 shares traded.

  • Midday Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 1:21 PM ET

    Baxter International Inc. rose$. 65 or 1.0 percent, to $68.99. Bristol-Myers Squibb Co. rose$. 30 or. 6 percent, to $49.26. Hospira rose$. 61 or 1.3 percent, to $48.73.

  • Early Glance: Pharmaceuticals companies Thursday, 16 Oct 2014 | 11:35 AM ET

    Baxter International Inc. fell $1.01 or 1.5 percent, to $67.33. Bristol-Myers Squibb Co. rose$. 25 or. 5 percent, to $49.21. Hospira rose$. 32 or. 7 percent, to $48.44.

  • Oct 16- Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow. The company, whose profit topped expectations for the fourth straight quarter, cut its 2014 earnings forecast to $4.86- $4.89 per share to exclude gains from its vaccine business that it...

  • *AbbVie board recommends shareholders vote against deal. *AbbVie to pay Shire $1.64 bln break fee if deal collapses. LONDON, Oct 16- U.S. drugmaker AbbVie has pulled the plug on its plan to buy Dublin- based Shire, recommending shareholders vote against the planned $55 billion takeover following new U.S. tax rules.